Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | STAT3 | P40763 | 5/20 | 0.45 |
| ▸ | SELE | P16581 | 6/20 | 0.44 |
| ▸ | AMY1A | P0DUB6 | 1/20 | 0.41 |
| ▸ | CD209 | Q9NNX6 | 2/20 | 0.41 |
| ▸ | LGALS8 | O00214 | 2/20 | 0.41 |
| ▸ | SELL | P14151 | 1/20 | 0.40 |
| ▸ | SELP | P16109 | 1/20 | 0.40 |
| ▸ | FGF1 | P05230 | 1/20 | 0.39 |
| ▸ | ENGASE | Q8NFI3 | 1/20 | 0.39 |
| ▸ | F10 | P00742 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24250550 | 1.00 | STAT3 (0.45) | STAT3SELEAMY1ACD209LGALS8 | |
| SCHEMBL22216227 | 0.89 | STAT3 (0.42) | STAT3SELEAMY1ACD209LGALS8 | |
| SCHEMBL24250552 | 0.88 | SELE (0.45) | STAT3SELEAMY1ACD209SELL | |
| SCHEMBL24060184 | 0.86 | SELE (0.44) | STAT3SELEAMY1ALGALS8SELL | |
| SCHEMBL19980833 | 0.85 | SELE (0.48) | STAT3SELEAMY1ALGALS8SELL | |
| SCHEMBL26264692 | 0.85 | AMY1A (0.45) | STAT3SELEAMY1ALGALS8SELL | |
| SCHEMBL10014361 | 0.85 | LGALS8 (0.45) | STAT3SELEAMY1ACD209LGALS8 | |
| SCHEMBL16869952 | 0.83 | AMY1A (0.47) | STAT3SELEAMY1ACD209 | |
| SCHEMBL16587627 | 0.83 | AMY1A (0.47) | STAT3SELEAMY1ACD209 | |
| SCHEMBL29632945 | 0.82 | SELE (0.50) | STAT3SELEAMY1ALGALS8SELL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220088060-A1 | NAIL COMPOSITIONS HAVING ANTIFUNGAL PROPERTIES | ISDIN, S.A. (ES) | 2022-03-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220088060-A1 | NAIL COMPOSITIONS HAVING ANTIFUNGAL PROPERTIES | NACA, PIK3C3, DPM1 | STAT3 955/4885SELE 1981/4885AMY1A 2127/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.